Can-Fite BioPharma Ltd. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
Can-Fite BioPharma Ltd. (CANF) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $340.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2026-03-26
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|
| 2025-12-31 | $340.00K 20-F · filed 2026-03-26 | |
| 2025-06-30 | $251.00K 6-K · filed 2025-08-28 | |
| 2024-12-31 | $362.00K 20-F · filed 2026-03-26 | |
| 2024-06-30 | $193.00K 6-K · filed 2025-08-28 | |
| 2023-12-31 | $261.00K 20-F · filed 2026-03-26 | |
| 2022-12-31 | $263.00K 20-F · filed 2025-04-14 | |
| 2021-12-31 | $398.00K 20-F · filed 2024-03-28 |